全文获取类型
收费全文 | 1190篇 |
免费 | 129篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 104篇 |
妇产科学 | 31篇 |
基础医学 | 290篇 |
口腔科学 | 20篇 |
临床医学 | 116篇 |
内科学 | 211篇 |
皮肤病学 | 13篇 |
神经病学 | 30篇 |
特种医学 | 81篇 |
外科学 | 114篇 |
综合类 | 16篇 |
预防医学 | 48篇 |
眼科学 | 60篇 |
药学 | 76篇 |
肿瘤学 | 98篇 |
出版年
2023年 | 6篇 |
2022年 | 5篇 |
2021年 | 29篇 |
2020年 | 19篇 |
2019年 | 23篇 |
2018年 | 27篇 |
2017年 | 23篇 |
2016年 | 21篇 |
2015年 | 31篇 |
2014年 | 29篇 |
2013年 | 33篇 |
2012年 | 39篇 |
2011年 | 48篇 |
2010年 | 34篇 |
2009年 | 39篇 |
2008年 | 40篇 |
2007年 | 44篇 |
2006年 | 48篇 |
2005年 | 46篇 |
2004年 | 29篇 |
2003年 | 34篇 |
2002年 | 36篇 |
2001年 | 44篇 |
2000年 | 29篇 |
1999年 | 33篇 |
1998年 | 37篇 |
1997年 | 44篇 |
1996年 | 49篇 |
1995年 | 33篇 |
1994年 | 44篇 |
1993年 | 20篇 |
1992年 | 41篇 |
1991年 | 47篇 |
1990年 | 33篇 |
1989年 | 26篇 |
1988年 | 28篇 |
1987年 | 20篇 |
1986年 | 11篇 |
1985年 | 16篇 |
1984年 | 5篇 |
1983年 | 13篇 |
1982年 | 10篇 |
1981年 | 6篇 |
1980年 | 12篇 |
1979年 | 7篇 |
1977年 | 3篇 |
1976年 | 6篇 |
1974年 | 4篇 |
1972年 | 4篇 |
1970年 | 2篇 |
排序方式: 共有1322条查询结果,搜索用时 15 毫秒
1.
2.
3.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
4.
Comparison of dynamic and step-and-shoot intensity-modulated radiation therapy planning and delivery. 总被引:1,自引:0,他引:1
Intensity-modulated radiation therapy (IMRT) is commonly delivered using the dynamic or segmental mode of multileaf collimators (DMLC or SMLC). Both methods are designed to deliver intensity-modulated beams as determined by inverse planning software. In this study, we have used the Helios IMRT planning system to generate ideal treatment plans for 10 cases of 2 common treatment sites (prostate and head and neck) and have investigated the actual treatment fluence distributions generated for each of the MLC leaf motion choices. The 2 dose delivery techniques were dosimetrically compared to each other and to the treatment plans. For each technique, point doses were measured in a water phantom using ionization chambers. Also for each technique, 2-dimensional dose distributions at a selected depth in a plastic phantom were obtained, using extended range film. The total delivery time and the number of monitor units (MU) delivered by each method were also compared. Our results indicate that the 2 delivery methods produce comparable results dosimetrically. For the cases reviewed, the delivery time was an average of 15% longer for SMLC deliveries, while the number of MUs (beam-on time) required by SMLC was an average of 15% fewer, than that for the DMLC. In the interest of simplicity, lower beam-on time, and potentially fewer mechanically-related problems, we think that the SMLC delivery technique may be the better choice when Helios is used for planning and Varian linear accelerators are used for delivery. 相似文献
5.
6.
Steven G. E. Marsh Ekkehard D. Albert Walter F. Bodmer Ronald E. Bontrop Bo Dupont Henry A. Erlich Daniel E. Geraghty John A. Hansen Bernard Mach Wolfgang R. Mayr Peter Parham Effie W. Petersdorf Takehiko Sasazuki Geziena M. Th. Schreuder Jack L. Strominger Arne Svejgaard Paul I. Terasaki 《International journal of immunogenetics》2002,29(6):463-515
7.
8.
9.
"Nonspecific" electrolytic lesions (with respect to subdivision) of the mouse inferior colliculus (IC) resulted in the attenuation of acoustic startle response (ASR) amplitudes on the 1st post-operative day, but ASR amplitudes increased to above baseline levels 1 week later. Lesions of the IC central nucleus (CN) also attenuated ASR amplitudes on the 1st postsurgery day, but startle amplitudes recovered to baseline levels 1 week after surgery. Lesions of the IC lateral nucleus (LN) or dorsal cortex (DC) resulted in elevation of startle amplitudes above baseline 7 days after surgery and produced enhanced ASR amplitudes to repeated stimuli. Fourteen days after the surgery, lesion effects on startle amplitudes remained the same as those on Day 7 for each lesion condition. The present findings implicate the ICLN and the ICDC as inhibitory modulators of the ASR, but indicate only a minor role for the ICCN. 相似文献
10.